Baxter (BAX) Trades Higher Following Dividend Boost, Buyback Increase
Tweet
Share
E-mailGet Alerts BAX Hot Sheet
Price: $22.65 +4.43%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
EPS Growth %: -37.3%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
EPS Growth %: -37.3%
Join SI Premium – FREE
Shares of Baxter (NYSE: BAX) are popping higher Wednesday morning after some positive announcements earlier.
The pharma giant boosted its quarterly payout 34 percent to 45 cents per share, yielding 3.3 percent at the current stock price.
In addition, Baxter approved a new $2 billion buyback plan, bringing total repurchases authorized to about $2.45 billion.
Shares are indicated nearly 2 percent better in pre-market action.
The pharma giant boosted its quarterly payout 34 percent to 45 cents per share, yielding 3.3 percent at the current stock price.
In addition, Baxter approved a new $2 billion buyback plan, bringing total repurchases authorized to about $2.45 billion.
Shares are indicated nearly 2 percent better in pre-market action.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- National Beverage (FIZZ) Declares $3.25 Special Dividend; 10.5% Yield
- Presidio acquires Canyon Creek assets for ~$83M, eyes dividend rise
- Starbucks (SBUX) Declares $0.62 Quarterly Dividend; 2.4% Yield
Create E-mail Alert Related Categories
Dividends, Insiders' Blog, Stock BuybacksRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
